Advertisement
Screener

NEUEHEALTH, INC. Increase (Decrease) in Accounts Payable and Other Operating Liabilities

NEUEHEALTH, INC. Increase (Decrease) in Accounts Payable and Other Operating Liabilities

NEUEHEALTH, INC. reported Increase (Decrease) in Accounts Payable and Other Operating Liabilities of -$12.48 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities · last filed 2025-08-07

  • NEUEHEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-06-30 was -$7.56M.
  • NEUEHEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-03-31 was -$4.92M.
  • NEUEHEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2024-12-31 was $244.00K.
  • NEUEHEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2024-09-30 was $10.20M.
  • NEUEHEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2024 was -$3.94M.
  • NEUEHEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2023 was -$149.32M, a 5638.76% decline from fiscal 2022.
  • NEUEHEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2022 was $2.70M, a 98.60% decline from fiscal 2021.
  • NEUEHEALTH, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2021 was $192.61M.
Period endIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 12 month
2025-06-30-$7.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$12.48M
10-Q · filed 2025-08-07
-$12.24M
derived: sum of 3 quarters · filed 2025-08-07
-$2.04M
derived: sum of 4 quarters · filed 2025-08-07
2025-03-31-$4.92M
10-Q · filed 2025-05-09
-$4.68M
derived: sum of 2 quarters · filed 2025-05-09
$5.53M
derived: sum of 3 quarters · filed 2025-05-09
-$3.25M
derived: sum of 4 quarters · filed 2025-08-07
2024-12-31$244.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
$10.45M
derived: sum of 2 quarters · filed 2025-03-21
$1.67M
derived: sum of 3 quarters · filed 2025-08-07
-$3.94M
10-K · filed 2025-03-21
2024-09-30$10.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$1.43M
derived: sum of 2 quarters · filed 2025-08-07
-$4.18M
10-Q · filed 2024-11-07
-$29.21M
derived: sum of 4 quarters · filed 2025-08-07
2024-06-30-$8.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$14.39M
10-Q · filed 2025-08-07
-$39.42M
derived: sum of 3 quarters · filed 2025-08-07
-$52.54M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$5.61M
10-Q · filed 2025-05-09
-$30.64M
derived: sum of 2 quarters · filed 2025-05-09
-$43.76M
derived: sum of 3 quarters · filed 2025-05-09
-$35.52M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31-$25.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
-$38.15M
derived: sum of 2 quarters · filed 2025-03-21
-$29.91M
derived: sum of 3 quarters · filed 2025-03-21
-$149.32M
10-K · filed 2025-03-21
2023-09-30-$13.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$4.88M
derived: sum of 2 quarters · filed 2024-11-07
-$124.30M
10-Q · filed 2024-11-07
-$100.41M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$8.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$111.17M
10-Q · filed 2024-08-13
-$87.29M
derived: sum of 3 quarters · filed 2024-08-13
-$143.79M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$119.42M
10-Q · filed 2024-05-10
-$95.53M
derived: sum of 2 quarters · filed 2024-05-10
-$152.03M
derived: sum of 3 quarters · filed 2024-05-10
-$168.90M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$23.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
-$32.62M
derived: sum of 2 quarters · filed 2024-03-28
-$49.49M
derived: sum of 3 quarters · filed 2024-03-28
$2.70M
10-K · filed 2024-03-28
2022-09-30-$56.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$73.37M
derived: sum of 2 quarters · filed 2023-11-09
-$21.19M
10-Q · filed 2023-11-09
$117.57M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$16.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$35.31M
10-Q · filed 2023-08-09
$174.07M
derived: sum of 3 quarters · filed 2023-08-09
$107.08M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$52.18M
10-Q · filed 2023-05-10
$190.94M
derived: sum of 2 quarters · filed 2023-05-10
$123.95M
derived: sum of 3 quarters · filed 2023-05-10
$214.70M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$138.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$71.76M
derived: sum of 2 quarters · filed 2023-03-16
$162.51M
derived: sum of 3 quarters · filed 2023-03-16
$192.61M
10-K · filed 2023-03-16
2021-09-30-$66.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$23.76M
derived: sum of 2 quarters · filed 2022-11-14
$53.85M
10-Q · filed 2022-11-14
$71.91M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30$90.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$120.85M
10-Q · filed 2022-08-15
$138.90M
derived: sum of 3 quarters · filed 2023-03-16
$163.26M
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31$30.10M
10-Q · filed 2022-05-12
$48.15M
derived: sum of 2 quarters · filed 2023-03-16
$72.51M
derived: sum of 3 quarters · filed 2023-03-16
2020-12-31$18.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$42.41M
derived: sum of 2 quarters · filed 2023-03-16
-$3.96M
10-K · filed 2023-03-16
2020-09-30$24.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$22.02M
10-Q · filed 2021-11-15
2020-06-30-$46.38M
10-Q · filed 2021-08-11
2019-12-31$25.55M
10-K · filed 2022-03-18